Ryan McDonald

January 07, 2022

Treatment with Calquence resulted in fewer toxicities, including atrial fibrillation, flutter and hypertension, in patients with previously treated chronic lymphocytic leukemia, compared with Imbruvica treatment, according to findings from the analysis of a phase 3 trial.

January 03, 2022

The use of Faslodex plus the investigational drug samuraciclib was considered safe in individuals with heavily pretreated hormone receptor-positive breast cancer.

December 22, 2021

The FDA’s recent greenlight of a new Keytruda indication gives a large group of patients with melanoma access to a treatment option that they didn’t previously have, says an expert from the UPMC Hillman Cancer Center.

December 15, 2021

Two different doses of Venclexta combined with Darzalex and the steroid dexamethasone elicited effective responses appeared safe in patients with t(11;14) relapsed/refractory multiple myeloma.

December 11, 2021

Using the presence of minimal residual disease to direct Imbruvica plus Venclexta treatment appears to be a feasible option for patients with relapsed/refractory chronic lymphocytic leukemia.

December 10, 2021

The use of pyrotinib — an experimental drug — plus the chemotherapy capecitabine extended survival compared with Tykerb and capecitabine among patients with pretreated HER2-positive metastatic breast cancer.

December 10, 2021

Early-phase study results showed that treatment with a novel drug elicits promising outcomes in patients with advanced or metastatic triple-negative breast cancer.

December 08, 2021

The use of elacestrant, an investigational therapy, elicited a 30% reduction in the risk of disease progression or death compared with standard of care in a group of patients with estrogen receptor (ER)–positive, HER2-negative metastatic breast cancer.

December 07, 2021

Black race is associated with a 3.5-fold increased incidence of lymphedema in women with breast cancer treated with axillary lymph node dissection and radiotherapy, according to recent data.

November 16, 2021

Imfinzi plus platinum-pemetrexed chemotherapy induced survival improvements in patients with previously untreated, unresectable malignant pleural mesothelioma, compared with chemotherapy alone.

November 10, 2021

From microbiome-based therapies to reinventing an old drug and more, an expert from City of Hope explains the interest around emerging treatment options and approaches in metastatic kidney cancer.

November 04, 2021

The FDA’s recommendations are aimed at helping individuals and patients with breast cancer make better informed decisions about the decision to receive breast implants, according to experts.

October 18, 2021

Colin Powell has died of complications from COVID-19 after receiving treatment for a blood cancer.

October 12, 2021

The genetic testing procedure may aid people with a history of hereditary cancer from passing those genetic mutations on to future children.

October 07, 2021

There’s a tremendous amount of interest in immunotherapy drugs given alongside targeted therapies for patients with pancreatic cancer, according to an expert.

October 05, 2021

An expert discusses two primary unmet needs in myelofibrosis, current treatments and new approaches to this complex disease.

October 04, 2021

One of the more prevalent misconceptions about inherited cancer mutations is that genetic testing is only for White people, according to a genetic counselor.

September 28, 2021

Here’s what patients should know about the recent FDA approval of Exkivity, the first oral therapy for patients with non-small cell lung cancer who have EFGR exon 20 insertion mutations.

September 22, 2021

The FDA approval of Brukinsa represents another treatment option with fewer side effects in patients with Waldenstrom's macroglobulinema, however it will not serve as a replacement for other therapies.

September 11, 2021

A retired New York City firefighter recalls his return to the city he once served for more than three decades on the day prior to the 9/11 terrorist attacks and all that followed, including his several bouts with lung cancer years after the dust had settled.

September 01, 2021

The FDA approval of Brukinsa, according to an expert from the Dana-Farber Cancer Institute, provides an important new option for targeted therapy in Waldenstrom’s macroglobulinemia.

August 23, 2021

Researchers are evaluating the safety and efficacy of zandelisib, an investigational cancer therapy, for the treatment of patients with marginal zone lymphoma and follicular lymphoma who have received at least two prior therapies.

August 20, 2021

Preliminary results of the phase 2 trial assessing the safety and efficacy of Cosela with gemcitabine/platinum-based chemotherapy and Bavencio maintenance therapy for metastatic bladder cancer are expected to be released in the second half of 2022.

August 17, 2021

People who meet regular dietary recommendations and the minimum daily requirement for vitamin D intake may experience a protection against early-onset colon cancer, according to an expert from the Dana-Farber Cancer Institute.

August 13, 2021

The FDA determined that individuals with weakened immune systems — which include patients with cancer — may benefit from a third dose of Pfizer-BioNTech’s and Moderna’s COVID-19 vaccines.

August 03, 2021

The results, according to the study authors, demonstrate that screening the general population for tubal and ovarian cancer each year does not result in a survival benefit.

July 23, 2021

The FDA’s recent approval of Keytruda in combination with trastuzumab and chemotherapy in the first-line setting is an exciting change for a group of patients with certain subtypes of stomach cancer, according to an expert.

July 22, 2021

The FDA’s recent approval of Rybrevant marks the first targeted therapy for a certain group of patients with non-small cell lung cancer, according to an expert at NYU Langone Health’s Perlmutter Cancer Center.

July 09, 2021

More than nine hours of surgery to remove a rare form of bone cancer in the his hip and leg forced Colin Jackson to relearn how to do simple tasks. Months later, he crossed the finish line of a marathon.

July 07, 2021

Patients with melanoma are living longer than ever before and some, according to an expert from the Rutgers Cancer Institute of New Jersey, are even getting cured or achieving long-term remissions thanks to developments in the treatment landscape.